Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 53 for “"Peripheral nerve sheath"”.
-
Molecular Characterization of the Spectrum of Peripheral Nerve Sheath Tumors
Malignant peripheral nerve sheath tumor (MPNST) is a highly aggressive sarcoma, and the most lethal form of cancer in the context of neurofibromatosis type 1. The current standard of care includes surgery plus radiation, with no effective chemo or targeted therapeutic options. Here we examined the …
-
Role of Ras Proteins in Malignant Peripheral Nerve Sheath Tumors
Malignant peripheral nerve sheath tumors (MPNSTs) arising in patients with neurofibromatosis type I (NF1) are null for the tumor suppressor neurofibromin, a negative regulator of signaling from both classic Ras (H-Ras, N-Ras and K-Ras) and R-Ras (R-Ras, R-Ras2/TC21, M-Ras/R-Ras3) subfamily members. …
-
Investigation of Molecular Therapeutic Targets in Malignant Peripheral Nerve Sheath Tumors
Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive softtissue sarcomas that commonly arise in patients with Neurofibromatosis Type I (NF1) syndrome. These tumors primarily follow a genetic etiology of successive tumor suppressor loss; first, loss of NF1, followed by loss of CDKN2A or …
-
A Collagen Droplet Platform For Screening Malignant Peripheral Nerve Sheath Tumors
The services of monolayer culture in probing underlying mechanisms around cancer cell biology are extensive and have resulted in novel findings that are too numerous to reference in this paper alone. Rather, broadly speaking, 2D has provided a cornerstone in understanding and exploration of …
-
Development of Novel Therapeutic Approaches for NF1 Deficient Peripheral Nerve Sheath Tumors
Malignant Peripheral Nerve Sheath Tumors (MPNSTs) associated with Neurofibromatosis Type 1 (NF1) pose a significant clinical challenge due to their aggressive nature and limited treatment options. This thesis endeavors to address this challenge by developing innovative therapeutic approaches for …
-
Mechanisms of AT101 [(-)-Gossypol] Induced Cytotoxicity in Malignant Peripheral Nerve Sheath Tumors
Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive Schwann cell-derived sarcomas and are the leading cause of mortality in patients with neurofibromatosis type 1 (NF1). Current treatment modalities have been largely ineffective resulting in a high rate of MPNST recurrence and poor …
-
Investigating the role of SWI/SNF in malignant peripheral nerve sheath tumours
Malignant peripheral nerve sheath tumours (MPNST) are rare and aggressive soft tissue sarcomas that are typically therapy resistant. Mutations of genes involved in the polycomb repressive complex 2 (PRC2), an important modulator of transcriptional repression, occur in up to 75% of MPNST cases. In …
-
Therapeutic Targeting Of Bmp2 In Nf1-Deficient Malignant Peripheral Nerve Sheath Tumors (mpnsts)
… type I (NF1)-deficient malignant peripheral nerve sheath tumor (MPNST) is an aggressive tumor for which the standard treatment is surgical removal with wide margins, often leaving behind cancer cells needing chemotherapy. RAS-GRD is the most widely studied functional target of NF1 …
-
Mechanisms Of Resistance To Oncolytic Herpes Simplex Viruses In Malignant Peripheral Nerve Sheath Tumors
Malignant peripheral nerve sheath tumors (MPNSTs) are rare but highly aggressive cancer of the peripheral nervous tissue. Median patient survival is approximately two years following diagnosis due in part to the ineffective options for treatment. As an alternative therapeutic approach to …
-
Functional translation of malignant peripheral nerve sheath tumour driver gene variants using CRISPR screens
<p>Malignant peripheral nerve sheath tumours (MPNSTs) are aggressive neural-crest cell derived sarcoma with limited treatment options, and only margin-free surgery as a potentially curative treatment option. The dire prognosis of these patients warrants the need for novel therapeutics. The …
-
ZNF423 Defines a Targetable Transcriptional Dependency in NF1-Associated Malignant Peripheral Nerve Sheath Tumors
Malignant peripheral nerve sheath tumors (MPNST) are aggressive sarcomas with limited effective systemic therapies and represent the leading cause of mortality in individuals with neurofibromatosis type 1 (NF1). While the genetic alterations underlying malignant transformation of benign plexiform …
-
Poly (Adp) Ribose Polymerase Inhibitors For The Treatment of Malignant Peripheral Nerve Sheath Tumor
Malignant peripheral nerve sheath tumor (MPNST) is a rare subtype of soft tissue sarcoma. Surgical excision has remained the standard of care for this highly aggressive malignancy for over a decade. Conventional chemotherapy and radiotherapy have shown limited efficacy in MPNST; therefore, it is …
-
Genes differentially expressed in Neurofibromatosis type 1 benign and malignant peripheral nerve sheath tumours
… harbour an increased risk of developing benign nerve sheath tumours such as dermal neurofibromas (dNFs) and plexiform neurofibromas (pNFs) and a 10% lifetime risk of developing malignant peripheral nerve sheath tumours (MPNST). MPNST that usually arise from pre-existing pNFs are highly …
-
Protective role of PACAP and VIP on Malignant Peripheral Nerve Sheath Tumor (MPNST) cells
Malignant peripheral nerve sheath tumors (MPNSTs) are often associated with poor prognosis and patient outcome. These tumors grow under conditions of metabolic stress caused by insufficient nutrients or oxygen. In our previous study we have identified PACAP, VIP and their receptors in rat MPNST …
-
Novel Small Molecule Induces Apoptosis in Malignant Peripheral Nerve Sheath Tumors of Neurofibromatosis Type I
… growths that can transform into malignant peripheral nerve sheath tumors (MPNSTs), a main cause of mortality. Currently, surgery is the primary course of treatment for MPNST, but with the limitation that these tumors are highly invasive. Radiotherapy is another treatment option, but is …
-
Identification of transcriptional mechanisms downstream of nf1 gene defeciency in malignant peripheral nerve sheath tumors
Malignant peripheral nerve sheath tumor (MPNST) is a type of soft tissue sarcoma that occurs in carriers of mutations in the neurofibromatosis type I gene (Nf1) as well as sporadically. Plexiform neurofibromas in NF1 patients have a significant risk of developing into MPNSTs leading to increased …
-
Modification of RHAMM and TPX2 optimizes Aurora kinase A (AURKA) inhibition in malignant peripheral nerve sheath tumours
Malignant peripheral nerve sheath tumours (MPNST) are rare, hereditary cancers associated with neurofibromatosis type I. MPNSTs lack effective treatments as they often resist chemotherapies and have high rates of disease recurrence. Published analysis of copy number variation identified hemizygous …
-
Targeting the intersection of molecular signaling pathways and tumor immunobiology in NF1-associated malignant peripheral nerve sheath tumors
Malignant peripheral nerve sheath tumors (MPNST) are a leading cause of death among patients with neurofibromatosis type 1 (NF1). MPNST are aggressive soft tissue sarcomas with a tendency for recurrence and distant metastases. They are difficult to treat because of their relative insensitivity to …
-
Determining the role of neuregulin-1 and its erbB receptors in the pathogenesis of malignant peripheral nerve sheath tumors
Malignant peripheral nerve sheath tumors (MPNSTs) are the most common cause of death in patients with neurofibromatosis type-1. These aggressive, Schwann cell-derived tumors have no treatment beyond surgical resection. Developing targeted chemotherapeutics remains crucial to improving patient …
-
Induction And Regulation Of Autophagy By Novel Prenylation Inhibitors In Sts-26t Malignant Peripheral Nerve Sheath Tumor (mpnst) Cells
… combination with lovastatin in STS-26T malignant peripheral nerve sheath tumor (MPNST) cells. We found that GGTI-2Z/lovastatin inhibit proliferation, cause cell cycle arrest in the G1 phase and induce autophagy in STS-26T MPNST cells. FTI-1/lovastatin not only inhibit proliferation and cause cell …
Page 1 of 3